Physician profile
Teresa Johnson
NPI 1841341500
$2,291.22
in general payments reported to CMS, 2019-2025
26 companies · $156 in 2025
The $156 reported for 2025 was more than what a typical Advanced Practice Midwife provider received nationally (typical 2025 total: $70.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $571 · 2022: $352 · 2023: $554 · 2024: $659 · 2025: $156.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,368.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,368.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $617.98 | 2021-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $402.44 | 2021-2024 | |
| Pfizer INC. | $296.69 | 2021-2024 | |
| Amgen INC. | $182.58 | 2021-2024 | Evenity, Prolia |
| Shield Therapeutics INC | $116.25 | 2023-2024 | Accrufer |
| Bayer Healthcare Pharmaceuticals INC. | $87.49 | 2021-2023 | |
| Baxter Healthcare | $67.66 | 2022-2023 | Perclot |
| Mayne Pharma Commercial LLC | $54.90 | 2024 | |
| Avion Pharmaceuticals | $54.69 | 2021-2023 | Balcoltra |
| Organon LLC | $50.77 | 2022-2023 | Nexplanon |
| Evofem Biosciences, INC. | $44.64 | 2021 | |
| Hologic Sales and Service, LLC | $39.40 | 2022-2023 | Acessa Provu System |
| Biohaven Pharmaceuticals, INC. | $34.05 | 2021 | |
| Aspira Women'S Health INC | $28.71 | 2024 | Ova1 |
| Glaxosmithkline, LLC. | $27.20 | 2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $21.82 | 2023 | Axonics |
| Davol INC. | $19.84 | 2024 | Arista Ah Flexitip |
| Sumitomo Pharma America, INC. | $18.06 | 2024 | Myfembree |
| Sage Therapeutics, LLC | $17.34 | 2024 | |
| Exact Sciences Corporation | $17.01 | 2024 | Cologuard Collection Kit |
| Therapeuticsmd, INC. | $16.67 | 2022 | |
| Channel Medsystems, INC. | $16.56 | 2024 | |
| Coloplast Corp | $16.23 | 2022 | |
| Millicent US INC | $15.06 | 2024 | Intrarosa, Femring |
| Agile Therapeutics, INC. | $13.62 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $13.56 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Teresa Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.